Lones Carrie E, Bond Gary R, McGovern Mark P, Carr Kathryn, Leckron-Myers Teresa, Hartnett Tim, Becker Deborah R
CODA, Inc., Portland, OR, USA.
, 1027 E. Burnside St., Portland, OR, 97214, USA.
Adm Policy Ment Health. 2017 May;44(3):359-364. doi: 10.1007/s10488-017-0793-2.
Individual Placement and Support (IPS) is an evidence-based employment model for people with severe mental illness, but it has not been evaluated for clients enrolled in substance abuse treatment programs. This study evaluated the effectiveness of IPS for people with opioid use disorders enrolled in an opioid treatment program. Within a randomized controlled experiment, 45 patients receiving methadone maintenance therapy were assigned to either IPS or a 6-month waitlist. The waitlist group received IPS after 6 months. The primary outcome assessed over 1 year compared the attainment of a job for the IPS condition to the waitlist comparison group. During the first 6 months after enrollment, 11 (50%) active IPS participants gained competitive employment compared to 1 (5%) waitlist participant (Χ = 12.0, p < 0.001). Over 12 months of enrollment, 11 (50%) IPS participants gained competitive employment compared to 5 (22%) waitlist participants (Χ = 3.92, p = 0.07). We conclude that IPS holds promise as an employment intervention for people with opioid use disorders in methadone maintenance treatment, but larger trials with longer follow-up are needed.
个体安置与支持（IPS）是一种针对重度精神疾病患者的循证就业模式，但尚未针对参加药物滥用治疗项目的客户进行评估。本研究评估了IPS对参加阿片类药物治疗项目的阿片类药物使用障碍患者的有效性。在一项随机对照试验中，45名接受美沙酮维持治疗的患者被分配到IPS组或6个月的等候名单组。等候名单组在6个月后接受IPS。在1年时间里评估的主要结果是比较IPS组与等候名单对照组的就业情况。在入组后的前6个月，11名（50%）积极参与IPS的参与者获得了竞争性就业，而等候名单组只有1名（5%）参与者获得了竞争性就业（Χ = 12.0，p < 0.001）。在入组后的12个月里，11名（50%）IPS参与者获得了竞争性就业，而等候名单组有5名（22%）参与者获得了竞争性就业（Χ = 3.92，p = 0.07）。我们得出结论，IPS有望作为一种就业干预措施用于接受美沙酮维持治疗的阿片类药物使用障碍患者，但需要进行更大规模、随访时间更长的试验。
